Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…e 0.5 mg/kg/day, tapered monthly to 5–10 mg/day over 12 months (prednisone group). All groups receive background standard therapy per guid…
… biochemical parameters. Budesonide and prednisone were weaned. Tofacitinib continues.Conclusions CD20+ cells play a regulatory and protect…
…n patients with systemic lupus erythematosus (SLE) treated with belimumab (BEL).Methods Retrospective longitudinal cohort study from the …
…o increase in any SLEDAI component since the previous visit, on prednisone (≤7.5 mg/day) and/or IS (maintenance dose); and active disease …
…citinib or upadacitinib), rituximab, tocilizumab, methotrexate, mycophenolate mofetil, or glucocorticoids (>=10 mg prednisone equivalent daily) for m…
…ac involvement was treated with CTX (CYCLOPS Regime) along with prednisone 40 mg.Both cases were closely monitored for their BP and renal …
…of RTX (cumulative dose of 8 g). The pts were also treated with mycophenolate mofetil 2000 mg/day continuously for the last 8 and 7 years, respective…
… had less peripheral synovitis (15% vs 72%, p<0.001). Time to a prednisone dose of 10 and 5 mg/day was comparable between groups. Patients…
… diffuse large B-cell lymphoma (DLBCL) who completed first-line rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone or ritu…
…e duration, higher cumulative dose of prednisone and the use of cyclophosphamide.Trial registration number NCT04534647.…
…in, famotidine, fentanyl, hydroxyzine, mirtazapine, prednisone, quetiapine.Anticholinergic risk varied depending on the scale used. The pr…
…lare risk, particularly in those achieving sustained remission. Belimumab use during remission emerged as an additional protective factor…